Use of finerenone for heart failure with preserved ejection fraction carries a hyperkalemia risk, especially in patients with kidney disease.

Research led by Professor Hai-Ling Margaret Cheng (BME) opens the door to earlier treatment and better outcomes ...

GAITHERSBURG, MD, USA I2, 2025 I Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, today ...

The company shared interim results from an ongoing Phase II trial examining its recombinant antibody fusion protein.

The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

The message is that an early decrease in eGFR with finerenone should not lead to stopping the medication, say HF experts.

Medications for myasthenia gravis (MG) can include cholinesterase inhibitors, corticosteroids, immunosuppressants, monoclonal antibodies, and antibody fragment medications. While myasthenia gravis ...

Faun1083 has demonstrated positive in-vivo efficacy in multiple preclinical animal models, including rat sugen hypoxia and ZSF1 studies, which are common models to study key features of heart failure ...

While HFpEF currently doesn’t have any approved ... While Tectonic Therapeutic is targeting a significant unmet medical need with a potentially best-in-class therapy, it faces the same risks ...

Also closely connected and in clinical practice often missed comorbidity in HFpEF are sleep disorders (Wester et al., 2023). Arrhythmias in this context are addressed by Hegner et al., investigating ...

USA: Recent findings published in Arthritis Care and Research suggest that individuals with rheumatoid arthritis (RA) face an increased risk of developing heart failure (HF) compared to those without ...

Ibuprofen (Advil or Motrin), naproxen (Aleve) and aspirin (Bayer or Ecotrin) are common pain relievers that belong to a class of medication called non-steroidal anti-inflammatory drugs (NSAIDs).